PAREXEL's Inaugural Podcast Focuses on International Women's Day
PAREXEL, the global provider of biopharmaceutical services, has today published its inaugural podcast with International Women’s Day as the focus. Hosted by Harvard Kennedy School expert Siri Chilazi, the podcast features the advice and expertise of some of PAREXEL’s most remarkable women in STEM.
Commenting on this year’s campaign theme, Ubavka DeNoble M.D., Corporate Vice President, Patient Technology, PAREXEL, said: “We now talk about a balanced boardroom, a balanced government, a balanced media approach. 15 years ago, that was a strange topic. There has been huge progress. We must remember that (any imbalance) is humanity’s issue and the only one way to resolve it is to work together: males and females.”
To listen to the full podcast – which features discussion around International Women’s Day from Ubavka DeNoble M.D. – Corporate Vice President of Patient Technology, Kemi Olugemo – Senior Director, Global Therapeutic Area Head, Aida Sabo – VP Diversity, and Peyton Howell – Chief Commercial and Strategy Officer – please click here.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
